Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
Jingying Zhou(Ningbo University Affiliated Hospital), Alfred S.L. Cheng(Chinese University of Hong Kong), Joanna H. Tong(Chinese University of Hong Kong), Leaf Huang(University of North Carolina at Chapel Hill), Charing C. N. Chong(National University of Singapore), King Lau Chow(Hong Kong University of Science and Technology), Joseph J.�Y. Sung(Nanyang Technological University), Ka‐Fai To(Chinese University of Hong Kong), Rihe Liu(University of North Carolina at Chapel Hill), Shun-Wa Tsang(Hong Kong University of Science and Technology), Hector Kwong-Sang Wang(Hong Kong University of Science and Technology), Zhiwei Chen(Fujian Medical University), Yu Feng(Central South University of Forestry and Technology), Liangliang Xu(Chinese University of Hong Kong), Man Liu(Chinese University of Hong Kong), Anthony W.H. Chan(Chinese University of Hong Kong), Paul B.S. Lai(Chinese University of Hong Kong), Hanyong Sun(Shanghai Jiao Tong University), John Wong(Chinese University of Hong Kong)
Cited by 203
Related Papers
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k